Novel therapeutic options bring hope to patients with rheumatic conditions--and to the physicians who treat them.
R M
RM
Pertusi
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D017060:Patient Satisfaction; D010818:Practice Patterns, Physicians'; D011320:Primary Health Care / Q000379:methods; D011720:Pyrazoles; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States
D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib